Cell and Gene Therapy Bioassay Services Market by Type of Therapy, Industry Trends and Global Forecasts, 2021-2030.
Roots Analysis has
announced the addition of Cell
and Gene Therapy Bioassay Services Market report
to its list of offerings.
During our research, we were able to capture more than 40
players, which claims to offer bioassay services related for cell and gene
therapies.
Amongst the total players offering bioassay services for
cell and gene therapies, most of the players engaged in this domain
were established before 1995. Of
these, nine are headquartered in North America, while eight are based in
Europe. Further, the industry witnessed the establishment of nine players, post 2010. Of
these, five are based in North America, three in Europe and one in the
Asia-Pacific region. In
addition to this, all of the bioassay service providers (100%) are offering
pre-developed assay. This is followed by 89% players that offer customized
assays for cell and gene therapies.
To request a sample copy / brochure of this
report, please visit this - https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/request-sample.html
Scope
of the Report –
The “Cell and Gene Therapy Bioassay Services
Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area
(Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare /
Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood
Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic
Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography
(North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the
World): Industry Trends and Global Forecasts, 2021-2030” report
features an extensive study of the current landscape and the likely future
potential of cell and gene therapy bioassay service providers, over the next
decade. The study also features an in-depth analysis, highlighting the
capabilities of various industry stakeholders engaged in this field. In
addition to other elements, the study includes:
- A detailed assessment of the
overall market landscape of the cell and gene therapy bioassay services market, providing information on
their year of establishment, company size, location of headquarters,
location of bioanalytical facilities, type of offering (in vitro and in
vivo), type of bioassay(s) offered (pre-developed assay and customized
assay), type of bioanalytical services (immunoassay, potency assay,
qualitative PCR, digital droplet PCR, flow cytometry, ELISA,
immunochemistry and others) and application area (cell therapy, gene
therapy and others).
- A detailed competitiveness
analysis of the cell and gene therapy bioassay service providers based in
different geographies, by taking into consideration their service strength
(in terms of bioassay offering(s) and number of bioanalytical services
offered), service applicability (in terms of number of bioassays offered
and application area) and supplier strength (in terms of years of
experience in this field and company size).
- Tabulated profiles of key players
offering a wide range of cell and gene therapy bioassay services across
North America, Europe and Asia-Pacific. Each profile includes an overview
of the company, financial information (if available), details of its cell
and gene therapy bioassay services portfolio, types of offerings, type of
bioassay(s) offered, types of bioanalytical services offered, application
area, location of bioanalytical facilities, recent developments and an
informed future outlook.
- An insightful contemporary market
trend analysis, featuring the distribution of cell and gene therapy
service providers by type of bioanalytical services offered and
application area and an analysis of cell and gene therapy service
providers, based on type of bioassay and types of bioanalytical services
offered. Further, the chapter also features a schematic world map
representation, highlighting the location of bioanalytical facilities of
cell and gene therapy bioassay service providers.
- A detailed analysis of the global
events attended by the service providers, based on year of event, type of
event, type of services involved and application area, and strategic
initiatives taken by various cell and gene therapy bioassay service
providers.
- A case study of the overall
landscape of cell and gene therapy therapeutics market, based on a number
of parameters. The market landscape of cell therapies, features
distribution of cell therapies across phase of development, therapeutic
area and type of developer. Further, the market landscape of cell
therapies, features distribution of gene therapies across phase of
development of pipeline candidates and key therapeutic areas. The chapter
also features information on the developers involved in the domain of cell
and gene therapies.
- An in-depth analysis of more than
260 cell therapy developers that are anticipated to partner with cell and
gene therapy bioassay service providers and have been shortlisted on the
basis of several relevant parameters, such as developer strength (which
takes into account a company’s size and its experience in this field),
pipeline strength and maturity (based on the number of pipeline drugs and
affiliated stage of development) and availability of other cell therapy
capabilities.
To
request a free insight to this report – https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/free-insights.html
Majority of the service
providers (56%) have established their facilities in North America; within this
region, most of the facilities are located in US (97%), followed by Canada
(3%). Further, close to 40% players have their manufacturing facilities in
Europe, while the remaining have established their facilities in Asia-Pacific
and rest of the world (~10%). It is worth highlighting that, in Asia-Pacific,
majority of the service providers have established their facilities in China
(75%), followed by Singapore (25%).
Further, as can be observed
from the figure, majority (66%) of the players offers type 1 assay for both
cell as well as gene therapies, followed by type 2 assay which is offered by
close to 60% bioassay service providers. Besides this, ~50% service providers
offer type 1 assay in in vitro medium, whereas only 30% players provide type 1
assay in in vivo medium. On the other hand, type 2 assay is offered by over 40%
of the service providers in in vitro medium and over 25% players provide type 2
assay in in vivo medium. Additionally, the other application area includes
vaccines, monoclonal antibodies, viral vectors and immuno-oncology.
To request a customization to this report – https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/request-customization.html
Key Questions Answered
- Who are the leading services
providers offering bioassay services related to cell and gene therapies?
- What is the relative
competitiveness of different cell and gene therapy bioassay service
providers?
- Which is the commonly offered
bioanalytical service (immunoassay, potency assay, qualitative PCR,
digital droplet PCR, flow cytometry, ELISA, immunochemistry and others)
related to cell and gene therapy?
- What are the key trends within the
cell and gene therapy bioassay service providers market?
- What kind of initiatives are being
taken by stakeholders engaged in this domain?
- Which players are likely to
partner with cell and gene therapy bioassay service providers?
- How is the current and future
opportunity likely to be distributed across key market segments?
- What are the anticipated future
trends related to teleradiology services market?
For
additional details, please visit - https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market.htmlOr sales@rootsanalysis.com
Roots Analysis is one of
the fastest growing market research companies, sharing fresh and independent
perspectives in the bio-pharmaceutical industry. The in-depth research,
analysis and insights are driven by an experienced leadership team which has
gained many years of significant experience in this sector. If you’d like help
with your growing business needs, get in touch at info@rootsanalysis.com
Contact Details
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Comments
Post a Comment